M&A Deal Summary

Cellectis Acquires Cyto Pulse Sciences

On September 9, 2010, Cellectis acquired medical products company Cyto Pulse Sciences for 2M USD

Acquisition Highlights
  • This is Cellectis’ 2nd transaction in the Medical Products sector.
  • This is Cellectis’ largest (disclosed) transaction.
  • This is Cellectis’ 1st transaction in the United States.
  • This is Cellectis’ 1st transaction in Maryland.

M&A Deal Summary
Date 2010-09-09
Target Cyto Pulse Sciences
Sector Medical Products
Buyer(s) Cellectis
Deal Type Add-on Acquisition
Deal Value 2M USD

Target

Cyto Pulse Sciences

Glen Burnie, Maryland, United States
Cyto Pulse Sciences specializing in the development, manufacture and commercialization of electroporation technology and equipment.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cellectis

Paris, France
Category Company
Founded 1999
Sector Life Science
Employees203
Revenue 50M EUR (2015)
DESCRIPTION

Cellectis is a gene-editing company focused on developing immunotherapies based on gene edited engineered CAR-T cells (UCART). Cellectis was founded in 1999 and is based in Paris, France.

DEAL STATS #
Overall 2 of 3
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 1 of 2
State (Maryland) 1 of 1
Country (United States) 1 of 1
Year (2010) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-10-12 Diatos - Vectocell Technology

France

The Vectocell technology platform can improve the performance of a therapeutic compound by enabling specific entry into the target cell compartment or organ in animals and humans.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-11-04 Cellartis AB

Gothenburg,, Sweden

Cellartis recognized as a premier provider of stem cell derived products and technologies. Company to bring to the market hepatocytes and cardiomyocytes derived from pluripotent stem cells for use as drug discovery tools and is widely.

Buy -
Mergr

Product

Company

Legal